In our most recent WorkCompWire Leaders Speak, Mitch Freeman explores how well-intended pharmacy regulations can backfire in workers’ comp. In “When Good Intentions Misfire in Workers’ Comp Pharmacy,” he highlights how opioid limits can drive costly alternatives, formulary gaps can inflate prices, and other rules can have unintended effects—and offers practical ways to improve outcomes. https://lnkd.in/eAbqVNa7
How pharmacy regulations can harm workers' comp
More Relevant Posts
-
In today’s WorkCompWire Leaders Speak, Mitch Freeman explores how well-intended pharmacy regulations can backfire in workers’ comp. In “When Good Intentions Misfire in Workers’ Comp Pharmacy,” he highlights real-world impacts like opioid limits driving costly alternatives and formulary gaps that inflate prices—and offers practical solutions to improve outcomes. 🔗 https://lnkd.in/eAbqVNa7
To view or add a comment, sign in
-
🩺 The Pharmacist as a Diagnostic Ally Pharmacy practice is no longer limited to dispensing. With point-of-care testing and clinical assessments, pharmacists can play a vital role in early detection, triage, and treatment decisions. Our role includes: 🩹 Rapid screening for conditions like strep, flu, or diabetes 🔎 Supporting differential diagnosis in primary care teams 🧭 Bridging patients into the right care pathway quickly 💭 What if your next “prescription” begins with a diagnostic test rather than a box of tablets? #PointOfCareTesting #ClinicalPharmacy #PrimaryCare #ConsultantPharmacist #pharmacy #nhs #persian #british
To view or add a comment, sign in
-
-
"There are two pharmacies that are closing per month in the state of Michigan, so obviously this is a cause for concern," said Faye Nemer, the CEO of MENA American Chamber of Commerce.
Michigan pharmacist is going after the #PBMs and GoodRx over price-fixing schemes. https://ow.ly/V1ko50XqwmV
Independent pharmacy suit accuses GoodRx of price-fixing scheme
cbsnews.com
To view or add a comment, sign in
-
When we meet as a Board monthly, there are often times we communicate new policies or updates. Please check out our latest Massachusetts Board of Pharmacy updates. Pharmacy practice documents, regulations, and other resources are available on the website. See below for new and updated information. Policy 2020-15: Scope of Practice Updates to this policy define "handling" of medications and that it requires an individual pharmacy license as well as defining the "prescription area" and who may access it. https://lnkd.in/e5YfEE_z New Pharmacy Labeling Requirement Pharmacies must now label Schedule VI medications prescribed for reproductive or gender-affirming care with the name and address of the healthcare practice instead of the individual prescriber upon request from the prescriber. https://lnkd.in/epgHvNqw
To view or add a comment, sign in
-
For too long, pharmacy success has meant Refills and prescriptions filled But let’s ask a tougher question: What if the true measure was How well patients actually feel? The next generation of pharmacy won’t just track pills They’ll track people Outcome based Pharmacy Is about more than counting bottles It brings together: - Medication adherence - Biometrics (think blood pressure, blood sugar, weight) - Symptom tracking, straight from the patient Suddenly, we’re not just asking “Did you pick up your meds?” We’re asking “Are you really getting better?” Here’s what excites me: Imagine pharmacists who help patients See their progress and adjust care in real time Imagine moving beyond transactions Toward true transformation in lives Not just ledgers Are we ready to leave behind old metrics That no longer serve us, or our patients? Let’s spark a new conversation Let’s challenge what we measure, and why PS. Subscribe to Pharmacy Unlocked newsletter for weekly insights that keep you informed, inspired, and ready to lead ⤵️ https://lnkd.in/eTa-8H2h #pharmacist #pharmd #pharmacy #outcomes #healthcare
To view or add a comment, sign in
-
-
Good faith prescribing...let's talk about it. I spent a good amount of time this week with a caregiver reviewing a patient’s medications. We found multiple prescriptions for the same drug with different strengths, from prescribers in different specialties. ❤️Those medications were prescribed in good faith to avoid gaps in care. There are many reasons why cross-prescribing happens. [That’s a topic for another day.] Unfortunately, this good-faith effort caused a lot of confusion for the family and for some of the providers involved. For anyone managing a chronic condition, medications prescribed in good faith to avoid gaps in care can be golden. But…let’s do so cautiously. ✅Prescribing Tips: -Limit to a month’s supply or to the confirmed next encounter with the actual provider managing the condition -Prescribe based on a confirmed dose, strength, and formulation using the actual medication bottle or the patient’s pharmacy. ✅Patient/Caregiver Tips: -Take the most recent medication bottles of ALL medications to every appointment. An updated medication list with dosing instructions/strengths/formulations will suffice -Keep all your providers updated on how you’re managing your care (with or without them) ✨No blame here. I suspect more of these scenarios happening with the rising cost of healthcare! ✨I hope this serves as your favorite pharmacist’s perspective on how to work together with safety in mind. Happy Friday LinkedIn friends!🤗 #PatientCare #AlignedInsights #Community #Pharmacy #Consultant #PharmD #MD #NP #PA #PatientAdvocate
To view or add a comment, sign in
-
-
Florida Hospitals Challenge Pharmacies in $1.5B Opioid Battle CVS Health, Walgreens, and Walmart cross-examined economist Joseph Mason as he testified that they could owe up to $1.5 billion to Florida hospitals for opioid-related patient care, debating whether damages should be based on hospitals' full chargemaster prices or actual payments received. Mason presented two models: one limited to opioid treatment codes ($528 million) and one utilizing payer-type categorization ($1.49 billion). Defense counsel argued that the larger estimate overlooks common billing practices and actual reimbursements. Mason clarified that his model represents economic costs rather than financial accounting, while acknowledging that it does not address prescription numbers or differentiate between legal and illicit opioid treatments. #Opioids
To view or add a comment, sign in
-
TWIRx News: First up, School of Pharmacy holds emergency management simulation, VCU Health pharmacies expand access through new home delivery options, Next, Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans. Our line up on TWIRx 11-07-2025 Amantha Bagdon - CEO of RxPost PGX Pharmacist's Protection of Patients: Updated FDA-approved label for Xeloda (capecitabine) Arkansas HB 1150 TO PROHIBIT A PHARMACY BENEFITS MANAGER FROM OBTAINING CERTAIN PHARMACY PERMITS. with John Vinson CEO of the Arkansas Pharmacy Association & Greg Reybold with APCI 4th Generation Pharmacy Owner C.O. Bigelow (the oldest Apothecary in America) the Drugstore Cowboy, Alec Gingsberg PharmD
PBM Reform in Arkansas & PGx Safeguards for Xeloda Patients
www.linkedin.com
To view or add a comment, sign in
-
The Minister for Health has signed legislation that will enable pharmacists to provide the new Common Conditions Service in community pharmacies. This service represents a significant advancement for patient care and pharmacy practice. It will expand community pharmacists’ ability to support and treat patients for an initial eight common conditions, including allowing pharmacists to prescribe certain medicines, where this is the most appropriate option. The PSI website has been updated with information about the Common Conditions Service, particularly outlining the enablers for pharmacists to provide the service to the public. Read the PSI statement: https://lnkd.in/gi9WshbK #Pharmacy #Healthcare #ProfessionalPractice #IIOP #PSI
To view or add a comment, sign in
-
-
📢 Big News for Non-Resident Pharmacies Operating in California! Did You Know? On October 1, 2025, California Assembly Bill 1503 (AB 1503) passed, ushering in sweeping changes for pharmacy operations both inside and outside the state. One of the most significant updates? New requirements for pharmacists-in-charge (PICs) at non-resident pharmacies. Starting July 1, 2026, non-resident pharmacies dispensing to California patients must: ❗ ✅ Designate and employ a California-licensed PIC ❗ ✅ Notify the California Board of Pharmacy of any PIC changes within a set timeframe ✅ Submit to Board inspections and pay associated costs This marks a major shift in compliance expectations and reinforces California’s commitment to patient safety and regulatory oversight. AB 1503 also strengthens PIC authority by prohibiting interference with their professional judgment and requiring them to establish technician ratios within statutory limits. Stay ahead of regulatory changes with RegComply™! Whether you’re a healthcare organization or pharmacy, our cutting-edge alert management platform ensures that the right alerts reach the right people, every time. Boost compliance, streamline regulatory processes, and enhance patient care. Schedule your demo today and experience the power of RegComply! https://d2rx.com/ https://lnkd.in/edksKzKu #PharmacyLaw #AB1503 #CaliforniaPharmacy #NonresidentPharmacy #PharmacistInCharge #HealthcareCompliance #RegulatoryUpdate
To view or add a comment, sign in
-